Dana-Farber Cancer Institute’s Post

View organization page for Dana-Farber Cancer Institute, graphic

139,217 followers

The Human Rights Campaign Foundation has once again named Dana-Farber as a 2024 LGBTQ+ Healthcare Equality Leader on its annual Healthcare Equality Index (HEI), the national benchmarking tool that evaluates health care facilities’ policies and practices related to the equity and inclusion of LGBTQ+ patients, visitors, and staff. The Institute is one of 384 health care facilities to earn this designation out of the 1,065 who participated in this year’s HEI. “What an honor to be recognized as a Healthcare Equity Leader by the Human Rights Campaign Foundation,“ remarks Ian Matthew-Clayton, vice president and chief Inclusion, Diversity, and Equity officer at Dana-Farber. “We believe everyone deserves the best possible cancer care, and we are committed to ensuring a respectful, welcoming, and equitable environment for our LGBTQ+ patients, their families and loved ones, and our workforce.“ Health care facilities are scored based on LGBTQ+ inclusive policies and practices in four criteria areas: foundational elements of LGBTQ+ patient-centered care; patient services and support; employee benefits and policies; and patient and community engagement. A crucial aspect of the HEI includes ensuring compliance with regulations that prohibit discrimination based on a person’s sexual orientation and gender identity, which fosters a supportive environment for LGBTQ+ patients and protects employees within those organizations.

  • No alternative text description for this image
Ellen Barnett

Strategic Communications Consultant @ Northeastern University | Marketing, Communications, Creative Direction

1mo

Such an important and singular statement about the organization. Congratulations.

Cindy Mackenzie

Co-chair of the Gay,Lesbian Bisexual,Transgender Employee Resource Group at Dana-Farber Cancer Institute

1mo

Makes me so proud.

Susan DeAngelis

Graphic Design and Brand Identity Development

1mo

Bravo!! 👏

See more comments

To view or add a comment, sign in

Explore topics